digest
Short Summary
Main recommendation: Get regular PSA testing, track the trend over time rather than judging a single number, and if PSA rises or stays concerning, use an MRI and PSA density before deciding on a biopsy, since prostate cancer caught early has near-100% five-year survival. The speaker argues the 2008 and 2012 US Preventive Services Task Force guidance against routine PSA screening contributed to more men being diagnosed with advanced cancer.
Key Points
- Prostate cancer usually grows slowly and has no early symptoms, so feeling fine does not rule it out; the only way to catch it early is to test.
- Dr. Kim says the five-year survival is about 100% when caught before spread, and around 97% at 15 years, versus about 38% once it reaches distant parts of the body.
- PSA measures prostate activity, not cancer directly; it is compared to a smoke alarm that can go off for reasons other than cancer. About three in four men with an elevated PSA do not have prostate cancer.
- Finasteride and dutasteride (used for hair loss and enlarged prostate) can lower PSA by about half, so a normal reading can hide cancer; the speaker suggests roughly doubling the reported value as a rough estimate, while stressing that the trend matters more.
- The speaker cites a veterans study in which men on finasteride/dutasteride were diagnosed with already-spread cancer at about 6.7% versus 2.9% for men not on them.
- The speaker says a reanalysis of the PLCO trial, correcting for hidden PSA testing in the control group, suggests regular PSA screening reduces prostate cancer deaths by roughly a quarter to a third.
Details Worth Noting
- Concrete instructions:
- Ask your doctor when to start PSA checks and record each result to track the trend over time, not a single reading.
- Before a PSA test, hold off sexual activity or ejaculation for about 2 days, since recent ejaculation can raise PSA by up to about 40%; riding a bike can also raise it because seat pressure hits the area.
- If your PSA is elevated or rising steadily, ask about an MRI of the prostate before a biopsy.
- Calculate PSA density (PSA relative to prostate size): a large prostate makes more PSA, so the same number from a bigger gland is less concerning.
- If you take finasteride or dutasteride, tell your doctor every time PSA is checked; a steady rise on these drugs is a red flag even if the number looks normal.
- Ask your doctor whether newer biomarkers such as PHI, 4Kscore, urine tests, or Stockholm3 (available in the US but not FDA approved) could help decide on biopsy or monitoring.
- A clean MRI lowers risk but does not eliminate it; the speaker cites roughly 1 in 10 men with a negative MRI still having a significant cancer.
- MRI-first pathways in the speaker's cited evidence found more dangerous cancers, fewer harmless ones, and let about one in four men skip biopsy.
- Traditional transrectal biopsy carries roughly a 5 to 7% infection risk, plus possible bleeding and pain.
- The speaker notes that biomarker blood and urine tests can be expensive and may not be covered by insurance, while PSA and MRI are usually covered.
- The speaker is a physician who states the video is educational and not medical advice; discuss any changes with your own doctor.
Bottom Line
Regular PSA tracking plus MRI and PSA density when results rise is the practical route to catching prostate cancer while it is still curable, and anyone on finasteride or dutasteride needs that context added to every reading.
